Phase 4 N=41 Treatment of OSA Associated Hypertension With Nebivolol or Hydrochlorothiazide
Hypertension
Primary: 24-h, Wake and Sleep Period Systolic and Diastolic Blood Pressure — 137; 130; 133; 82 mmHg
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=561 Long-term Immunogenicity After Receipt of JE Vaccine and Antibody Response and Safety to a Booster Dose
Encephalitis, Japanese
Primary: Seroprotection Rate Three and Four Years After Initial Vaccination With CD-JEV — 9.2; 9.8; 9.3; 12.5 percentage of participants
Phase 4 N=30 Effect of Dapagliflozin on Blood Pressure Variability in Prediabetes and Prehypertension
PreDiabetes · Prehypertension
Primary: 24-hours Systolic Blood Pressure at Week 12 — 117; 120 mmHg — p=0.755
Phase 4 N=22 Flu Vaccine Study in Neuromuscular Patients 2011
Duchenne Muscular Dystrophy · Spinal Muscular Atrophy · Congenital Muscular Dystrophy
Primary: Geometric Mean Titer Ratio for Each Vaccine Strain — 3.76; 3.53; 2; 1.46 geometric mean titer ratio — p=<.05
Phase 4 N=259 Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Viral Intestinal Infections in Children
Viral Intestinal Infection
Primary: Average Diarrhea Duration. — 43.4; 54.7 hours — p=0.004
Phase 4 N=46 Control of Pain in Intravitreal Injections Using Topical NSAIDs
Intravitreal Injections · IVI
Primary: McGill Pain Questionnaire (SF-MPQ) Scores at Baseline — 0.62; 0.93; 0.53 score on a scale
Phase 4 N=131 Extension Study to Gather Data on Effect of Macugen on the Corneal Endothelium
Age-Related Macular Degeneration · Retinal Vein Occlusion · Diabetic Macular Edema
Primary: Change From Baseline in Mean Endothelial Cell Density — -35.86 cells/millimeter squared
Phase 4 N=32 Topiramate Treatment of Hazardous and Harmful Alcohol Use in Veterans With TBI
Traumatic Brain Injury (TBI) · Hazardous and Harmful Alcohol Use
Primary: Change in the Number of Drinking Days Per Week as Assessed by the Timeline Followback (TLFB) — 2.2; 1.6 Drinking Days per week
Phase 4 N=68 Cost- Effectiveness and Quality of Life Assessment in Major Depression Disorder
Depression
Primary: Number of Participants With Response to Treatment — 58 Participants
Phase 4 N=78 Cost- Effectiveness and Quality of Life Assessment in Bipolar Disorder Depressive Episode
Bipolar Disorder
Primary: Number of Participants With Response to Treatment" — 65 Participants
Phase 4 N=22 Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis
Asthma · Allergic Rhinitis
Primary: The Effect of Omnaris Nasal Spray & Alvesco Inhalation Aerosol vs Beconase AQ Nasal Spray & QVAR Inhalation Aerosol on Short-term Lower Leg Growth Velocity as Measured…
Phase 4 N=86 Opioid-Free Shoulder Arthroplasty
Opioid Use · Shoulder Osteoarthritis · Avascular Necrosis
Primary: Post Op Pain — 3.0; 2.0 score on a scale — p=.297
Phase 4 N=564 Aromasin® Interventional Study Of Early Invasive Breast Cancer Patients In China
Breast Neoplasms
Primary: Time-to-Event — NA months
Phase 4 N=32 Effect of Flovent Discus vs QVAR vs Pulmicort Flexhaler on Short Term Growth
Asthma
Primary: Short-term Lower Leg Growth During Treatment With Flovent Diskus 100 mcg BID or Pulmicort Flexhaler 180 mcg BID. — 0.37; 0.21 mm/wk
Phase 4 N=39 Allergic Rhinitis Changes the Sinus Microbiome
Seasonal Allergic Rhinitis
Primary: Total Nasal Symptom Score (TNSS) — 67.1; 78.0 score on a scale — p=0.391